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nology, pediatrics, nutrition, epidemiology, public health, 
and health economics evaluated the evidence on specific 
questions within five working groups. The consensus group, 
representing 11 international scientific organizations, par-
ticipated in a multiday conference in May 2014 to reach a 
global evidence-based consensus.  Results: This consensus 
document defines nutritional rickets and its diagnostic crite-
ria and describes the clinical management of rickets and os-
teomalacia. Risk factors, particularly in mothers and infants, 
are ranked, and specific prevention recommendations in-
cluding food fortification and supplementation are offered 
for both the clinical and public health contexts.  Conclusion: 
Rickets, osteomalacia, and vitamin D and calcium deficien-
cies are preventable global public health problems in in-
fants, children, and adolescents. Implementation of interna-
tional rickets prevention programs, including supplementa-
tion and food fortification, is urgently required. 
 © 2016 S. Karger AG, Basel and The Endocrine Society 
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 Abstract 
 Background: Vitamin D and calcium deficiencies are com-
mon worldwide, causing nutritional rickets and osteomala-
cia, which have a major impact on health, growth, and devel-
opment of infants, children, and adolescents; the conse-
quences can be lethal or can last into adulthood. The goals 
of this evidence-based consensus document are to provide 
health care professionals with guidance for prevention, di-
agnosis, and management of nutritional rickets and to pro-
vide policy makers with a framework to work toward its erad-
ication.  Evidence: A systematic literature search examining 
the definition, diagnosis, treatment, and prevention of nutri-
tional rickets in children was conducted. Evidence-based 
recommendations were developed using the Grading of 
Recommendations, Assessment, Development and Evalua-
tion (GRADE) system that describes the strength of the rec-
ommendation and the quality of supporting evidence.  Pro-
cess: Thirty-three nominated experts in pediatric endocri-
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 Summary of Consensus Recommendations 1 
 Section 1: Defining Nutritional Rickets and the 
Interplay between Vitamin D Status and Calcium 
Intake 
 1.1 Definition and Diagnosis of Nutritional Rickets 
 • Nutritional rickets (NR), a disorder of defective chon-
drocyte differentiation and mineralization of the 
growth plate and defective osteoid mineralization, is 
caused by vitamin D deficiency and/or low calcium 
intake in children. (1 ⨁ ⨁ ⨁ ) 
 • The diagnosis of NR is made on the basis of history, 
physical examination, and biochemical testing, and is 
confirmed by radiographs. (1⨁ ⨁ ⨁ ) 
 1.2 Vitamin D Status 
 • The panel recommends the following classification of 
vitamin D status, based on serum 25-hydroxyvitamin 
D (25OHD) levels: (1⨁ ⨁ ⨁ ) 
 – Sufficiency, >50 nmol/l 
 – Insufficiency, 30–50 nmol/l 
 – Deficiency, <30 nmol/l 
 1.3 Vitamin D Toxicity 
 • Toxicity is defined as hypercalcemia and serum 
25OHD >250 nmol/l, with hypercalciuria and sup-
pressed parathyroid hormone (PTH). (1⨁ ⨁ ⨁ ) 
 1.4 Dietary Calcium Intake to Prevent Rickets 
 • For infants 0–6 and 6–12 months of age, the adequate 
calcium intake is 200 and 260 mg/day, respectively. 
(1⨁ ⨁ ⨁ ) 
 • For children over 12 months of age, dietary calcium 
intake of <300 mg/day increases the risk of rickets in-
dependently of serum 25OHD levels. (1 ⨁ ⨁○ ) 
 • For children over 12 months of age, the panel recom-
mends the following classification of dietary calcium 
intake: (1 ⨁ ⨁○) 
 – Sufficiency, >500 mg/day 
 – Insufficiency, 300–500 mg/day 
 – Deficiency, <300 mg/day 
 1.5 Vitamin D Deficiency and Fractures 
 • Children with radiographically confirmed rickets have 
an increased risk of fracture. (1 ⨁ ⨁○) 
 • Children with simple vitamin D deficiency are not at 
increased risk of fracture. (1 ⨁ ⨁○) 
 Section 2: Prevention and Treatment of Nutritional 
Rickets and Osteomalacia 
 2.1 Vitamin D Supplementation for the Prevention of 
Rickets and Osteomalacia 
 • 400 IU/day (10 μg) is adequate to prevent rickets and is 
recommended for all infants from birth to 12 months of 
age, independently of their mode of feeding. (1 ⨁ ⨁ ⨁ ) 
 • Beyond 12 months of age, all children and adults need 
to meet their nutritional requirement for vitamin D 
through diet and/or supplementation, which is at least 
600 IU/day (15 μg), as recommended by the Institute 
of Medicine (IOM). (1 ⨁ ⨁ ⨁ ) 
 2.2 Target for Vitamin D Supplementation 
 • In healthy children, routine 25OHD screening is not 
recommended, and consequently, no specific 25OHD 
threshold for vitamin D supplementation is targeted in 
this population. (1 ⨁ ⨁ ⨁ ) 
 2.3 Candidates for Preventative Vitamin D 
Supplementation beyond 12 Months of Age 
 In the absence of food fortification, vitamin D supple-
mentation should be given to:
 • Children with a history of symptomatic vitamin D de-
ficiency requiring treatment (1 ⨁ ⨁ ⨁ ) 
 • Children and adults at high risk of vitamin D deficien-
cy, with factors or conditions that reduce synthesis or 
intake of vitamin D (1 ⨁ ⨁ ⨁ ) 
 • Pregnant women (see section 3.1) 
 2.4 Dose of Vitamin D and Calcium for the 
Treatment of Nutritional Rickets 
 • For the treatment of NR, the minimal recommended 
dose of vitamin D is 2,000 IU/day (50 μg) for a mini-
mum of 3 months. (1 ⨁ ⨁ ⨁ ) 
 • Oral calcium, 500 mg/day, either as dietary intake or 
supplement, should be routinely used in conjunction 
with vitamin D in the treatment regardless of age or 
weight. (1 ⨁ ⨁ ⨁ ) 
 2.5 Appropriate Route of Administration and 
Duration of Therapy 
 • We recommend oral treatment, which more rapidly 
restores 25OHD levels than intramuscular treatment. 
(1 ⨁ ⨁ ⨁ ) 
 • For daily treatment, both D 2 and D 3 are equally effec-
tive. (1 ⨁ ⨁ ⨁ ) 
 • When single large doses are used, D 3 appears to be 
preferable compared to D 2 because the former has a 
longer half-life. (1 ⨁ ⨁ ⨁ ) 
 1   Grading of evidence: 1 = strong recommendation; 2 = weak recommen-
dation. Quality of evidence: ⨁⨁⨁ = high;  ⨁ ⨁○ = moderate; ⨁○○ = low 
quality. 
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 • Vitamin D treatment is recommended for a minimum 
of 12 weeks, recognizing that some children may re-
quire a longer treatment duration. (1 ⨁ ⨁ ⨁ ) 
 Section 3: Prevention of Nutritional Rickets/
Osteomalacia: Identification of Risk Factors 
 3.1 Dietary Practices and Nutrient Intakes among 
Mothers Associated with Nutritional Rickets in 
Infants 
 • Maternal vitamin D deficiency should be avoided by 
ensuring that women of childbearing age meet intakes 
of 600 IU/day recommended by the IOM. (1 ⨁ ⨁ ⨁ ) 
 • Pregnant women should receive 600 IU/day of vitamin 
D, preferably as a combined preparation with other 
recommended micronutrients such as iron and folic 
acid. (2 ⨁ ⨁○ ) 
 3.2 Early Feeding, Supplementation, Complementary 
Feeding, and Nutrient Intake Associated with Rickets 
in Infants 
 • In addition to an intake of 400 IU/day of vitamin D, 
complementary foods introduced no later than 26 
weeks should include sources rich in calcium. (1 ⨁ ⨁ ⨁ ) 
 • An intake of at least 500 mg/day of elemental calcium 
must be ensured during childhood and adolescence. 
(1 ⨁ ⨁ ⨁ ) 
 3.3 Association of Sunlight Exposure with 
Nutritional Rickets 
 • Because ultraviolet B (UVB) rays trigger epidermal 
synthesis of previtamin D 3 , restricted exposure to sun 
increases the risk of vitamin D deficiency and NR. 
(1 ⨁ ⨁ ⨁ ) 
 • Environmental factors, such as latitude, season, time 
of day, cloud cover, and pollution affect the availabil-
ity of UVB, whereas personal factors, such as time 
spent outdoors, skin pigmentation, skin coverage, age, 
body composition, and genetics affect the dose re-
sponse of UVB exposure and circulating 25OHD. 
(2 ⨁ ⨁○) 
 • No safe threshold of UV exposure allows for sufficient 
vitamin D synthesis across the population without in-
creasing skin cancer risk. (2 ⨁ ⨁○) 
 Section 4: Prevention of Osteomalacia during 
Pregnancy and Lactation and Congenital Rickets 
 4.1 The Relationship between Vitamin D during 
Pregnancy and Infant Growth and Bone Mass 
 • Pregnant women should receive 600 IU/day of supple-
mental vitamin D. This will ensure adequacy of mater-
nal 25OHD, especially in women at risk of deficiency, 
to prevent elevated cord blood alkaline phosphatase 
(ALP), increased fontanelle size, neonatal hypocalce-
mia and congenital rickets, and to improve dental 
enamel formation. (2 ⨁ ⨁○) 
 • There is little evidence that maternal supplementation 
with vitamin D will protect or improve birth anthro-
pometry (2 ⨁ ○○) and no evidence that supplementa-
tion with vitamin D will protect or improve short- or 
long-term growth or bone mass accretion. (2 ⨁ ⨁○) 
 4.2 The Effect of Calcium Supplementation during 
Pregnancy on Infant Bone Mass 
 • Pregnant women do not need calcium intakes above 
recommended nonpregnant intakes to improve neo-
natal bone. (1 ⨁ ⨁ ⨁ ) 
 4.3 Influence of Calcium or Vitamin D 
Supplementation in Pregnancy or Lactation on 
Breast Milk Calcium or Vitamin D 
 • Lactating women should ensure they meet the dietary 
recommendations for vitamin D (600 IU/day) for their 
own needs, but not for the needs of their infant. 
(1 ⨁ ⨁ ⨁ ) 
 • Lactating women should not take high amounts of 
 vitamin D as a means of supplementing their infant. 
(2 ⨁ ⨁○) 
 • Pregnant and lactating women should meet the rec-
ommended intakes of calcium. Maternal calcium in-
take during pregnancy or lactation is not associated 
with breast milk calcium concentrations. (1 ⨁ ⨁ ⨁ ) 
 4.4 Causes and Therapy of Congenital Rickets 
 • Supplementing mothers with 600 IU/day of vitamin D 
and ensuring they receive recommended calcium in-
takes, or appropriate therapy of maternal conditions 
predisposing to hypocalcemia or vitamin D deficiency, 
prevent congenital rickets. (2 ⨁ ○○) 
 Section 5: Assessing the Burden of Nutritional Rickets 
and Public Health Strategies for Prevention 
 5.1 Assessment of Disease Burden 
 • The prevalence of rickets should be determined by 
population-based samples, by case reports from senti-
nel centers, or by mandatory reporting. (1 ⨁ ⨁ ⨁ ) 
 • Screening for NR should be based on clinical features, 
followed by radiographic confirmation of suspected 
cases. (1 ⨁ ⨁ ⨁ ) 
 • Population-based screening with serum 25OHD, se-
rum ALP, or radiographs is not indicated. (1 ⨁ ⨁ ⨁ ) 
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 5.2 Public Health Strategies for Rickets Prevention 
 • Universally supplement all infants with vitamin D 
from birth to 12 months of age, independently of their 
mode of feeding. Beyond 12 months, supplement all 
groups at risk and pregnant women. Vitamin D sup-
plements should be incorporated into childhood pri-
mary health care programs along with other essential 
micronutrients and immunizations (1 ⨁ ⨁ ⨁ ), and 
into antenatal care programs along with other recom-
mended micronutrients. (2 ⨁ ⨁○) 
 • Recognize NR, osteomalacia, and vitamin D and cal-
cium deficiencies as preventable global public health 
problems in infants, children, and adolescents. 
(1 ⨁ ⨁ ⨁ ) 
 • Implement rickets prevention programs in popula-
tions with a high prevalence of vitamin D deficiency 
and limited vitamin D and/or calcium intakes, and in 
groups of infants and children at risk of rickets. 
(1 ⨁ ⨁ ⨁ ) 
 • Monitor adherence to recommended vitamin D and 
calcium intakes and implement surveillance for NR. 
(1 ⨁ ⨁ ⨁ ) 
 • Fortify staple foods with vitamin D and calcium, as ap-
propriate, based on dietary patterns. Food fortification 
can prevent rickets and improve vitamin D status of 
infants, children, and adolescents if appropriate foods 
are used and sufficient fortification is provided, if for-
tification is supported by relevant legislation, and if the 
process is adequately monitored. Indigenous food 
sources of calcium should be promoted or subsidized 
in children. (1 ⨁ ⨁ ⨁ ) 
 • Promote addressing the public health impact of vita-
min D deficiency as both a clinical and a public health 
issue. (1 ⨁ ⨁ ⨁ ) 
 5.3 Economic Cost/Benefits of Prevention Programs 
 • The cost-effectiveness of supplementation and food 
fortification programs needs further study. (1 ⨁ ⨁○ ) 
 Nutritional rickets (NR), secondary to vitamin D defi-
ciency and/or dietary calcium deficiency, remains a sig-
nificant global, public health problem despite the avail-
ability of supplementation and numerous published 
guidelines for its prevention  [1–8] . This is concerning be-
cause NR can have a major impact on the health of in-
fants, children, and adolescents, with ramifications that 
persist into adulthood. The morbidity and mortality as-
sociated with NR can be devastating, with substantial but 
poorly recognized consequences for society and health 
economics. Features of NR and osteomalacia include: (1) 
hypocalcemic seizures and tetanic spasms; (2) life-threat-
ening hypocalcemic cardiomyopathy; (3) bone pain and 
muscle weakness; (4) limb and pelvic deformities; (5) fail-
ure to thrive; (6) developmental delay, and (7) dental 
anomalies  [9, 10] . Alarmingly, NR can also lead to death 
from heart failure caused by hypocalcemic cardiomyopa-
thy, even in developed countries  [11] . In addition, nar-
rowing of the pelvic outlet after NR in childhood can re-
sult in obstructed labor and maternal and fetal death  [12] .
 Despite an intense focus around the role of vitamin D 
status in health and disease, there has been a worldwide 
failure to implement public health guidance and eradicate 
the severest manifestations of vitamin D and calcium de-
ficiency in our most vulnerable population – NR and os-
teomalacia of childhood. Therefore, the goal of this Con-
sensus Statement is to provide clinicians with clarity and 
recommendations on the recognition, societal burden, 
and treatment of NR and osteomalacia, and to enable cli-
nicians and health policy leaders to establish appropriate 
clinical and public health interventions to prevent this 
debilitating, costly, and underrecognized global health 
problem.
 Methods 
 In recognition of the considerable variation in the definition, 
diagnosis, and management of NR worldwide, the European Soci-
ety for Pediatric Endocrinology decided to examine the current 
best practice in NR and to formulate evidence-based recommen-
dations. Experts were assembled from the following societies: the 
Pediatric Endocrine Society (PES), the Asia Pacific Pediatric En-
docrine Society (APPES), the Japanese Society for Pediatric Endo-
crinology (JSPE), the Sociedad Latino-Americana de Endocri-
nología Pediátrica (SLEP), the Australasian Pediatric Endocrine 
Group (APEG), the Indian Society for Pediatric and Adolescent 
Endocrinology (ISPAE), the African Society for Pediatric and Ad-
olescent Endocrinology (ASPAE), the Chinese Society of Pediatric 
Endocrinology and Metabolism (CSPEM), the British Nutrition 
Society, and the European Society for Pediatric Gastroenterology, 
Hepatology and Nutrition (ESPGHAN). This consensus paper in-
cludes the cumulative evidence up to the end of 2014.
 Participants included individuals from Europe, North America 
(United States and Canada), Latin America, Asia, Africa, and Aus-
tralia, with a balanced spectrum of professional seniority and ex-
pertise. In addition, an expert on the development of evidence-
based guidelines served in an advisory capacity. Panel members 
declared any potential conflict of interest at the initial meeting of 
the group. Thirty-three participants were assigned to one of five 
groups to which topics 1–5 were allocated, and a chairperson was 
designated for each group. Each participant prepared an evidence-
based summary of the literature relating to a particular question 
distributed before the conference (which was held over 3 days in 
May 2014).
 Each group presented the revised summaries for discussion to 
the full conference. This report is based on the questions ad-
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dressed. A detailed description of the GRADE (Grading of Recom-
mendations, Assessment, Development and Evaluation) classifica-
tion has been published elsewhere  [13] . Recommendations were 
based on published findings and on expert opinion when appro-
priate.
 The best available research evidence was used to develop rec-
ommendations. Preference was given to articles written in English, 
identified by PubMed searches with MeSH terms. For each point, 
recommendations and evidence are described, with a modification 
in the grading evidence as follows: 1 = strong recommendation 
(applies to most patients in most circumstances, benefits clearly 
outweigh the risk); 2 = weak recommendation (consensus opinion 
of working group or should be considered; the best action may de-
pend on circumstances or patient values, benefits, and risks close-
ly balanced or uncertain). Quality of evidence is indicated as fol-
lows:  ⨁ ⨁ ⨁ = high quality [prospective cohort studies or ran-
domized controlled trials (RCTs) at low risk of bias];  ⨁ ⨁ ○ = 
moderate quality (observational studies or trials with methodolog-
ical flaws, inconsistent or indirect evidence);  ⨁ ○○ = low quality 
(case series or nonsystematic clinical observations)  [13] .
 The target audience for these guidelines includes general and 
specialist pediatricians, other professionals providing care for pa-
tients with NR, and health policy makers, particularly in countries 
with developing economies.
 1 Defining Nutritional Rickets and the Interplay 
between Vitamin D Status and Calcium Intake 
 1.1 Definition and Diagnosis of Nutritional Rickets 
 1.1.1 Recommendations 
 • NR, a disorder of defective chondrocyte differentia-
tion and mineralization of the growth plate and de-
fective osteoid mineralization, is caused by vitamin D 
 deficiency and/or low calcium intake in children. 
(1 ⨁ ⨁ ⨁ ) 
 • The diagnosis of NR is made on the basis of history, 
physical examination, and biochemical testing and is 
confirmed by radiographs. (1 ⨁ ⨁ ⨁ ) 
 1.1.2 Evidence 
 Bone mineralization requires sufficient supply of the 
essential mineral ions, calcium and phosphate, with vita-
min D optimizing their absorption from the gut. With 
insufficient serum calcium concentration caused by ei-
ther vitamin D deficiency or inadequate dietary calcium 
intake, parathyroid hormone (PTH) will stimulate osteo-
clastic bone resorption to release stored bone minerals 
into the bloodstream and maintain normal serum calci-
um  [14] . Bone disease (rickets and osteomalacia) devel-
ops once elevated PTH has led to low serum phosphate 
levels, as a result of impaired renal phosphate conserva-
tion  [15] .
 NR is a disorder of defective growth plate chondrocyte 
apoptosis and matrix mineralization in children. Osteo-
malacia is abnormal matrix mineralization in established 
bone, and although present in children with rickets, it is 
used to describe bone mineralization defects after com-
pletion of growth. Children with an underlying disease 
such as fat malabsorption, liver disease, renal insufficien-
cy, and illnesses necessitating total parenteral nutrition 
can also develop NR and are briefly discussed in this re-
view. NR does not include rickets associated with heri-
table disorders of vitamin D metabolism, including 1-α-
hydroxylase deficiency and vitamin D receptor defects, or 
congenital or acquired hypophosphatemic rickets.
 The clinical features and consequences of NR are 
broad and potentially severe ( table 1 )  [8] . Defective min-
eralization leads to radiographic growth plate widening 
as well as metaphyseal cupping and fraying, which con-
firm the diagnosis of NR.
 Biochemical testing alone is not sufficient to diagnose 
NR and may not differentiate whether the primary cause 
 Table 1.  Clinical features associated with NR
Osseous signs and symptoms
Swelling wrists and ankles
Delayed fontanelle closure (normally closed by the age of 2 years)
Delayed tooth eruption (no incisors by the age of 10 months, no 
molars by 18 months)
Leg deformity (genu varum, genu valgum, windswept deformity)
Rachitic rosary (enlarged costochondral joints – felt anteriorly, 
lateral to the nipple line) 
Frontal bossing
Craniotabes (softening of skull bones, usually evident on 
palpation of cranial sutures in the first 3 months)
Bone pain, restlessness, and irritability
Radiographic features
Splaying, fraying, cupping, and coarse trabecular pattern of 
metaphyses
Widening of the growth plate
Osteopenia
Pelvic deformities including outlet narrowing (risk of obstructed 
labor and death)
Long-term deformities in keeping with clinical deformities
Minimal trauma fracture
Nonosseous features
Hypocalcemic seizure and tetany
Hypocalcemic dilated cardiomyopathy (heart failure, arrhythmia, 
cardiac arrest, death)
Failure to thrive and poor linear growth
Delayed gross motor development with muscle weakness
Raised intracranial pressure
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of NR is vitamin D or dietary calcium deficiency because 
combined deficiencies are common. Typical laboratory 
findings in NR are decreases in 25-hydroxyvitamin D 
(25OHD), serum phosphorus, serum calcium, and uri-
nary calcium. Conversely, serum PTH, alkaline phospha-
tase (ALP), and urinary phosphorus levels are invariably 
elevated  [10, 16] .
 Vitamin D status is assessed by measuring blood levels 
of total 25OHD. Total 25OHD is used, assuming that 
25OHD 2 and 25OHD 3 are of equal biological value  [16] . 
There is considerable variability between laboratory 
methods for measuring serum 25OHD concentrations 
 [17] . Immunoassays are popular due to their conve-
nience and high sample throughput; however, cross- 
reactivity between vitamin D metabolites [25OHD 2 , 
25OHD 3 , and 24,25(OH) 2 D] and high levels of estimated 
bias in several automated assays cast doubt on their reli-
ability, particularly at high and low concentrations of 
25OHD  [18] . Higher-order reference measurement pro-
cedures for serum 25OHD have been established by the 
National Institute of Standards and Technology (NIST) 
 [19] and Ghent University  [20] based on isotope dilution 
liquid chromatography-tandem mass spectrometry. In 
recent years, the accuracy of 25OHD assays has im-
proved, also by activities of the Vitamin D Standardiza-
tion Program  [21] , which aims to standardize the results 
of different measurement techniques to those of the ref-
erence measurement procedures  [22] . Significant reduc-
tions in interlaboratory variation in serum 25OHD are 
observed using liquid chromatography-tandem mass 
spectrometry with the application of NIST standard ref-
erence materials  [23] .
 Dietary calcium deficiency is diagnosed by obtaining 
a calcium intake history. Because the sources of calcium 
will vary by country and region, we recommend that cli-
nicians develop a dietary calcium intake questionnaire 
specific to their country/region.
 1.2 Vitamin D Status 
 1.2.1 Recommendation 
 • The panel recommends the following classification of 
vitamin D status, based on serum 25OHD levels: 
(1 ⨁ ⨁ ⨁ ) 
 – Sufficiency, >50 nmol/l 
 – Insufficiency, 30–50 nmol/l 
 – Deficiency, <30 nmol/l 
 1.2.2 Evidence 
 Our definition of vitamin D deficiency in the context 
of skeletal mineralization and mineral ion metabolism for 
the prevention of NR is based on strong evidence  [1, 2, 
24–27] supported by the increased incidence of NR with 
25OHD concentrations <30 nmol/l (1 ng/ml = 2.5 nmol/l). 
Our definition is consistent with that of the Institute of 
Medicine (IOM)  [28] . The potential health impacts of 
maintaining a serum concentration >50 nmol/l are be-
yond the scope of this review and are addressed elsewhere 
 [29] . It should be noted that NR has been reported in chil-
dren with 25OHD concentrations >30 nmol/l  [2, 5, 6, 30] 
and that NR may not occur with very low 25OHD con-
centrations but is more likely to occur with deficiency 
sustained over time, i.e. chronic deficiency. Most children 
with vitamin D deficiency are asymptomatic  [15] , high-
lighting the interplay between serum 25OHD level and 
dietary calcium intake in maintaining serum calcium 
concentrations and bone integrity ( fig. 1 ).
 Although the most significant functional outcome of 
vitamin D deficiency is the development of osteomalacia 
and NR, biochemical and bone density associations are 
also reported. Laboratory observations demonstrate that 
PTH increases when 25OHD levels drop below 34 nmol/l 
 [7] . Moreover, all patients with NR in that study had 
25OHD levels <34 nmol/l, and PTH was elevated in all 
but 1 patient. Taken together, the evidence suggests that 
a 25OHD level at 30–34 nmol/l may be the critical cutoff 
below which NR is more likely to occur.
 Seasonal variations in 25OHD of between 13 and 24 
nmol/l  [31] emphasize the importance of maintaining 
25OHD levels >50 nmol/l (i.e. sufficient), so as to prevent 
prolonged periods of 25OHD levels <30 nmol/l, with the 
risk of developing NR.
 1.3 Vitamin D Toxicity 
 1.3.1 Recommendation 
 • Toxicity is defined as hypercalcemia and serum 
25OHD >250 nmol/l with hypercalciuria and sup-
pressed PTH 2 . (1 ⨁ ⨁ ⨁ ) 
 1.3.2 Evidence 
 Intoxication is predominantly seen in infants and 
young children after exposure to high doses of vitamin D 
(240,000–4,500,000 IU)  [32–37] . High 25OHD concen-
trations can cause hypercalcemia, hypercalciuria, and, if 
prolonged, nephrocalcinosis and renal failure. To allow a 
 2   In areas where 25OHD assays are not readily available, suppression of 
PTH in the presence of hypercalcemia and pharmacological doses of vitamin 
D may support the diagnosis of vitamin D toxicity. When a PTH assay is also 
unavailable, the possibility of toxicity should be considered in the presence 
of symptomatic hypercalcemia in association with pharmacological doses of 
vitamin D.
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large safety margin, the consensus group felt it prudent to 
use the concentration of 250 nmol/l as the recommended 
upper limit of serum 25OHD – even if symptomatic tox-
icity from RCTs has only been reported at levels >500 
nmol/l  [32] . In otherwise healthy infants, hypercalcemia 
and hypercalciuria in the absence of elevated 25OHD 
concentrations have been reported and may be related to 
genetic variation in vitamin D metabolism  [38, 39] .
 1.4 Dietary Calcium Intake to Prevent Rickets 
 1.4.1 Recommendations 
 • For infants 0–6 and 6–12 months of age, the adequate 
calcium intake is 200 and 260 mg/day, respectively. 
(1 ⨁ ⨁ ⨁ ) 
 • For children over 12 months of age, dietary calcium 
intake of <300 mg/day increases the risk of rickets in-
dependently of serum 25OHD levels. (1 ⨁ ⨁ ○) 
 • For children over 12 months of age, the panel recom-
mends the following classification of dietary calcium 
intake: (1 ⨁ ⨁ ○) 
 – Sufficiency, >500 mg/day 
 – Insufficiency, 300–500 mg/day 
 – Deficiency, <300 mg/day 
 1.4.2 Evidence 
 In developing countries where calcium intake is char-
acteristically very low, with few or no dairy products, di-
etary calcium deficiency is the main cause of NR among 
children outside the infant age group.
 In 2011, the IOM recommended adequate intakes of 
calcium for infants, children, and adults  [16] . The ade-
quate intake for infants was based on breast milk calci-
um content, which is 200 and 260 mg/day for babies 0–6 
and 6–12 months of age, respectively. For children 1–18 
years of age, the IOM set the daily calcium requirement 
at 700–1,300 mg/day, depending on age  [28] . There is, 
however, no true definition of dietary calcium deficien-
cy without a reliable biomarker of calcium intake status, 
and there are little data to indicate what the lowest cal-
cium intake is that prevents NR. Reports from Nigeria, 
India, and Bangladesh  [6, 30, 40–43] highlighted the 
role of low dietary calcium intake in the pathogenesis of 
NR among children. Although some of these children 
also had suboptimal 25OHD, others had values >50 
nmol/l, which points to the interplay between calcium 
and vitamin D in the pathogenesis of NR ( fig. 1 ). These 
studies suggest that in children >12 months of age, a di-
etary calcium intake of <300 mg/day significantly in-
creases the risk of NR independently of serum 25OHD 
levels, and that at a daily intake of >500 mg, no NR was 
seen.
 1.5 Vitamin D Deficiency and Fractures 
 1.5.1 Recommendations 
 • Children with radiographically confirmed rickets have 
an increased risk of fracture. (1 ⨁ ⨁ ○) 
 • Children with simple vitamin D deficiency are not at 
an increased risk of fracture. (1 ⨁ ⨁ ○) 
 Fig. 1. Biochemical disturbances in rickets 
pathogenesis based on a three-stage classi-
fication of vitamin D status (symbolized by 
the sun) and calcium intake (symbolized by 
a glass of milk). Figure modified from Hö-
gler [246], with permission by Elsevier 
2015. 
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 1.5.2 Evidence 
 Based on evidence from available observational stud-
ies and case reports, children with clinical, biochemical, 
and radiographic evidence of NR are at an increased risk 
of fracture. A retrospective study found that fractures oc-
curred in 7 of 45 (17.5%) infants and toddlers with NR, 
aged between 2 and 14 months  [44] . However, fractures 
only occurred in those who were mobile and had severe 
radiographic evidence of rickets. Although none of the 
fractures were considered to be characteristic of nonac-
cidental injury (child abuse), 2 infants had lateral or an-
terior-lateral rib fractures. In a national survey in Canada, 
11 of 108 cases of NR (11%) had suffered fractures, al-
though details on the bone sites and numbers of fractures 
were not provided  [1] . Fractures also have been reported 
in cases or case series of NR in toddlers and adolescents 
 [45–50] , but details about the number, site, and type of 
fracture were absent. 
 It has been suggested that radiographic features of 
rickets may be mistaken for those characteristic of nonac-
cidental injury  [51, 52] , but the necessary biochemical 
and radiographic data on the cases for validation of the 
authors’ conclusions were absent. In addition, serum 
25OHD levels are similar in infants with accidental and 
nonaccidental injuries  [53] . Thus, simple vitamin D defi-
ciency, that is vitamin D deficiency without biochemical 
or radiological signs of rickets, has not been associated 
with an increased fracture risk in infants and children.
 2 Prevention and Treatment of Nutritional Rickets 
and Osteomalacia 
 2.1 Vitamin D Supplementation for the Prevention of 
Rickets and Osteomalacia 
 2.1.1 Recommendations 
 • 400 IU/day (10 μg) is adequate to prevent rickets and 
is recommended for all infants from birth to 12 months 
of age, independently of their mode of feeding. 
(1 ⨁ ⨁ ⨁ ) 
 • Beyond 12 months of age, all children and adults need 
to meet their nutritional requirement for vitamin D 
through diet and/or supplementation, which is at least 
600 IU/day (15 μg), as recommended by the IOM. 
(1 ⨁ ⨁ ⨁ ) 
 2.1.2 Evidence 
 Few published studies have included the prevention of 
radiographic or clinical signs of rickets as an outcome. 
Consequently, we also reviewed studies that assessed the 
effect of different vitamin D supplementation regimens 3 
on 25OHD levels and other bone parameters (such as bone 
mineral density) with the goal of preventing NR by main-
taining levels above the rachitic range, i.e. >30 nmol/l  [54] .
 In infants and children, 400 IU/day of vitamin D giv-
en as a supplement during infancy is sufficient to prevent 
radiographic signs of rickets in the short term (up to 12 
months)  [54] . Specifically, an RCT demonstrated that a 
vitamin D supplement of 400 IU/day was sufficient to pre-
vent radiographic signs of rickets at 6 months of age, even 
among infants born with vitamin D deficiency  [25] . Simi-
larly, no cases of radiographically confirmed rickets were 
seen after administration of 400 IU/day of vitamin D for 
12 months, whereas the incidence was 3.8% in Turkish 
infants and young children who did not receive supple-
mentation  [55] . In addition, no incident cases of radio-
graphically confirmed rickets were reported in a 2-year 
surveillance study of Canadian infants who received 400 
IU/day of vitamin D  [1] . Worldwide, there have been no 
reports of radiographically confirmed rickets in infants or 
children receiving 400 IU on a regular, daily basis. Fur-
thermore, this dose has been shown in RCTs to achieve 
25OHD levels more frequently above the rachitic (severe 
deficiency) range compared to 100 or 200 IU/day  [25] .
 The prevention of vitamin D deficiency in the absence 
of NR was also briefly reviewed. In a double-blind RCT 
of infants without vitamin D deficiency (25OHD >50 
nmol/l), the impact of 400, 800, 1,200, and 1,600 IU of 
vitamin D 3 per day was assessed  [54] . Doses of 400 IU/
day maintained 25OHD levels >50 nmol/l in 97% of in-
fants after 12 months; doses of 800 and 1,200 IU/day were 
of no added benefit to bone mineral density parameters, 
and 1,600 IU/day raised concerns about potential toxici-
ty. A study in infants with vitamin D deficiency (25OHD 
<25 nmol/l) found that a single dose of 100,000 IU main-
tained 25OHD levels above 37.5 nmol/l for 3 months 
without hypercalcemia, whereas higher doses led to unac-
ceptably high 25OHD levels  [56] .
 Among infants and toddlers with 25OHD levels <50 
nmol/l for whom daily vitamin D supplementation may 
not be ideal, intermittent bolus doses of 50–100,000 IU 
every 3 months hold promise, although a comprehensive 
understanding of the safety and efficacy of this approach 
remains to be studied.
 3 Note that the term ‘supplementation’ may be interpreted to mean addi-
tional vitamin D provided from supplements, general multivitamins, or food 
fortification. In the context of this article, vitamin D supplementation refers 
to vitamin D above that which is found in standard dietary sources, with the 
exception of fortified infant formula. 
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 2.2 Target for Vitamin D Supplementation 
 2.2.1 Recommendation 
 • In healthy children, routine 25OHD screening is not 
recommended, and consequently, no specific 25OHD 
threshold for vitamin D supplementation is targeted in 
this population. (1 ⨁ ⨁ ⨁ ) 
 2.2.2 Evidence 
 No studies have specifically examined the best moni-
toring approach once supplementation has been given to 
prevent vitamin D deficiency rickets. 25OHD is a reason-
able monitoring parameter to ensure levels >30–34 nmol/l 
for the prevention of NR. Biochemically, a fall in 25OHD 
concentration <34 nmol/l is associated with rising PTH 
levels, but this intersection point depends on the prevail-
ing calcium intake  [7] .
 The frequent coexistence of dietary calcium deficiency 
and vitamin D deficiency alters the threshold for rickets 
development  [57] . Similarly, monitoring 25OHD con-
centrations as a public health policy for all individuals is 
impractical; fortunately, high-risk groups can easily be 
identified based on clinical profile ( table 2 ).
 2.3 Candidates for Preventative Vitamin D 
Supplementation beyond 12 Months of Age 
 2.3.1 Recommendations 
 In the absence of food fortification, vitamin D supple-
mentation should be given to:
 • Children with a history of symptomatic vitamin D de-
ficiency requiring treatment (1 ⨁ ⨁ ⨁ ) 
 • Children and adults at high risk of vitamin D deficien-
cy with factors or conditions that reduce synthesis or 
intake of vitamin D (1 ⨁ ⨁ ⨁ ) 
 • Pregnant women (see section 3.1) 
 2.3.2 Evidence 
 Supplementation is a feasible and acceptable way to 
ensure adequate vitamin D intake independently of nutri-
tion  [58] . Consensus guidelines for vitamin D supple-
mentation have been drafted from a variety of pediatric/
endocrine groups  [16, 59–62] . Although there are numer-
ous studies regarding vitamin D deficiency in pediatric 
populations and primary evaluations of the efficacy of 
various programs for supplementation of pregnant wom-
en, breast-feeding mothers, infants, children, and adoles-
cents, there is more opinion than evidence on many as-
pects of this topic. However, there is strong, high-quality 
evidence that vitamin D supplementation should be pro-
vided for at-risk groups. All at-risk groups ( table 2 ) are 
specifically vulnerable and, in the absence of food fortifi-
cation, require supplementation.
 Vitamin D fortification of infant formula is well estab-
lished and recommended by all European countries, Aus-
tralia, New Zealand, and the American Academy of Pedi-
atrics  [60] . Vitamin D fortification of milk is mandated in 
Canada, and ‘enriched milk’ is voluntarily fortified in the 
United States  [63] .
 Children with chronic illnesses and conditions affect-
ing vitamin D synthesis/absorption/metabolism may also 
benefit from supplementation and may require higher 
doses  [58] but are not in the remit of this consensus on 
NR.
 2.4 Dose of Vitamin D and Calcium for the Treatment 
of Nutritional Rickets 
 2.4.1 Recommendations 
 • For the treatment of NR, the minimal recommended 
dose of vitamin D is 2,000 IU/day (50 μg) for a mini-
mum of 3 months. (1 ⨁ ⨁ ⨁ ) 
 Table 2.  Risk factors for NR and osteomalacia and their prevention
Maternal factors
Vitamin D deficiency
Dark skin pigmentation
Full body clothing cover
High latitude during winter/spring season
Other causes of restricted sun (UVB) exposure, e.g. 
predominant indoor living, disability, pollution, 
cloud cover
Low vitamin D diet
Low calcium diet
Poverty, malnutrition, special diets
Infant/childhood factors
Neonatal vitamin D deficiency secondary to maternal
deficiency/vitamin D deficiency
Lack of infant supplementation with vitamin D
Prolonged breast-feeding without appropriate
complementary feeding from 6 months
High latitude during winter/spring season
Dark skin pigmentation and/or restricted sun (UVB) 
exposure, e.g. predominant indoor living, disability, 
pollution, cloud cover
Low vitamin D diet
Low calcium diet
Poverty, malnutrition, special diets
Risk factors are prevented by:
Sun exposure (UVB content of sunlight depends on latitude and 
season)
Vitamin D supplementation
Strategic fortification of the habitual food supply
Normal calcium intake
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 • Oral calcium, 500 mg/day, either as dietary intake or 
supplements, should be routinely used in conjunction 
with vitamin D in the treatment regardless of age or 
weight. (1 ⨁ ⨁ ⨁ ) 
 2.4.2 Evidence 
 Most studies claim that the different doses common-
ly employed to treat vitamin D deficiency are safe, with 
hypercalcemia and/or hypercalciuria observed as a side 
effect only in a few individuals and usually seen in the 
300,000- to 600,000-IU range  [64] . In a small study of 
children with NR (n = 17), doses of 1,700–4,000 IU of vi-
tamin D 2 rapidly increased 25OHD concentrations with-
in 1 week and normalized calcium, phosphate, and ALP 
levels at 10 weeks  [65] . In another study in children aged 
2–36 months with NR (n = 19), 5,000–10,000 IU of oral 
vitamin D 3 and calcium 0.5–1.0 g daily normalized serum 
PTH, calcium, and phosphate within 3 weeks, although 
ALP levels remained elevated  [66] .
 Simultaneous administration of calcium with vitamin 
D appears to be adequate and recommended by several 
studies  [67, 68] . In 123 Nigerian children with NR due to 
calcium deficiency, the combined end point of an ALP 
level <350 U/l and radiographic evidence of near-com-
plete healing of rickets was seen in a higher percentage of 
patients who received a combination of calcium and vita-
min D (58%) or calcium alone (61%) than in those who 
received vitamin D alone (19%)  [5] . Similarly, in 67 In-
dian children with NR due to combined calcium and vi-
tamin D deficiency, complete healing at 12 weeks was 
seen in a higher percentage with combined therapy (50%) 
than with vitamin D (15.7%) or calcium alone (11.7%) 
 [30] .
 Combined treatment is justified because studies have 
shown that the diet of children and adolescents with NR 
is generally low in both vitamin D and calcium  [5, 6, 30, 
69] .
 2.5 Appropriate Route of Administration and 
Duration of Therapy 
 2.5.1 Recommendations 
 • We recommend oral treatment, which more rapidly 
restores 25OHD levels than intramuscular (IM) treat-
ment. (1 ⨁ ⨁ ⨁ ) 
 • For daily treatment, both D 2 and D 3 are equally effec-
tive. (1 ⨁ ⨁ ⨁ ) 
 • When single large doses are used, D 3 appears to be 
preferable compared to D 2 because the former has a 
longer half-life. (1 ⨁ ⨁ ⨁ ) 
 • Vitamin D treatment is recommended for a minimum 
of 12 weeks, recognizing that some children may re-
quire a longer treatment duration. (1 ⨁ ⨁ ⨁ ) 
 2.5.2 Evidence 
 Some studies compared IM and oral administration of 
vitamin D, but most were conducted in adults and, there-
fore, may not be entirely relevant for children with NR. 
Oral or IM vitamin D was given to 24 normal volunteers 
(age, 50–78 years) in a dose of 600,000 IU of D 2 or D 3  [70] . 
Peak levels of 25OHD were seen at 30 and 120 days in 
those given oral and IM treatment, respectively. Another 
study in 92 adults with 25OHD <75 nmol/l compared 
300,000 IU vitamin D 3 IM to 50,000 IU D 3 orally given on 
6 occasions over 3 months  [71] . A higher proportion of 
subjects receiving oral treatment had 25OHD >75 nmol/l 
at 3 and 6 months than IM subjects.
 One RCT in 61 children with NR compared a single 
IM dose of 600,000 IU vitamin D 3 to a weekly oral dose 
of 60,000 IU D 3 for 10 weeks  [72] . There were no differ-
ences at 1, 4, and 12 weeks between groups in bone pro-
files, 25OHD concentrations, or side effects. A meta-anal-
ysis of studies comparing the administration of vitamin 
D 2 and D 3 concluded that, when given as bolus doses, 
vitamin D 3 was more effective at raising 25OHD concen-
trations, but no significant differences were seen with dai-
ly doses  [73] .
 There are no RCTs on the duration of treatment for 
children with NR, and most of the literature consists of re-
view articles. The review commissioned by the PES recom-
mends that daily oral treatment be given for 8–12 weeks 
 [74] . Similar durations between 8 and 12 weeks of daily 
treatment are recommended in reviews from the United 
Kingdom  [75, 76] . A duration of 3 months is recommend-
ed in a consensus statement from Australia and New Zea-
land  [77] . Given the limited evidence, we recommend a 
minimum treatment duration of 12 weeks to achieve a 
comprehensive healing and normalization of ALP, recog-
nizing that some children may require a longer treatment.
 Several studies explored the concept of ‘stoss thera-
py,’ i.e. the administration of a large dose given as a sin-
gle dose or in divided doses over several days. This ap-
proach has been advocated for ease of use and compliance 
with therapy. Three different single oral doses (150,000, 
300,000, or 600,000 IU) in 56 Turkish children aged 3–36 
months with NR did not affect the rate of improvement 
of rickets at 30 days  [64] .
 However, 8 subjects (2 in the 300,000-IU group, 6 in 
the 600,000-IU group) developed hypercalcemia. A re-
cent study in India compared single oral doses of 300,000 
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versus 600,000 IU of vitamin D 3 in 76 rachitic children 
aged 6 months to 5 years  [78] . At 12 weeks, all children 
demonstrated radiographic healing with comparable de-
creases in ALP and PTH. However, hypercalcemia oc-
curred in 5 children (6.5%) – 2 receiving 300,000 IU and 
3 receiving 600,000 IU. Several review articles advocate 
different recommendations with stoss therapy that are 
not supported by evidence  [75–77] . The few studies com-
paring daily treatment to stoss therapy contained groups 
with different subject characteristics. Although we rec-
ommend daily treatment as the first line of management, 
we recognize that in some situations, stoss therapy may 
be more practical. Therefore, we provide vitamin D dose 
recommendations for both treatment options ( table 3 ). 
Any treatment needs to be followed by supplementation 
(see sections 2.1 and 2.3).
 3 Prevention of Nutritional Rickets/Osteomalacia: 
Identification of Risk Factors 
 3.1 Dietary Practices and Nutrient Intakes among 
Mothers Associated with Nutritional Rickets in Infants 
 3.1.1 Recommendations 
 • Maternal vitamin D deficiency should be avoided by 
ensuring that women of childbearing age meet the 
 intakes of 600 IU/day recommended by the IOM. 
(1 ⨁ ⨁ ⨁ ) 
 • Pregnant women should receive 600 IU/day of vitamin 
D, preferably as a combined preparation with other 
recommended micronutrients such as iron and folic 
acid. (2 ⨁ ⨁ ○) 
 3.1.2 Evidence 
 Maternal diet and nutrient intake as a predictor of in-
fantile rickets have not been addressed in the literature as 
an a priori hypothesis. However, available data have been 
collected during vitamin D intervention studies, case 
studies, or case series in women during pregnancy.
 Many cases of NR included data on maternal 25OHD 
and, in some cases, dietary information  [79–81] . Neona-
tal vitamin D deficiency is always caused by maternal de-
ficiency and can have life-threatening consequences such 
as hypocalcemic seizures and dilated cardiomyopathy in 
unsupplemented infants  [11] . Hypocalcemia (see section 
4.1.2) or other early biochemical signs of rickets (such as 
elevated ALP and PTH) are present before radiographic 
signs of NR occur in unsupplemented neonates and in-
fants  [82, 83] . A high percentage of mothers of infants 
with symptomatic vitamin D deficiency are from high-
risk groups who are vitamin D deficient and exclusively 
breast-feeding  [11, 24, 83–85] .
 In a Canadian case series, 6 First Nation infants
presented with hypocalcemic seizures within the first
30 days of life, with suspected or confirmed maternal 
vitamin D deficiency and a lack of supplementation 
during pregnancy  [86] . All were formula fed, which sug-
gests that although their intake of vitamin D would have 
been sufficient in normal circumstances, in these in-
fants the oral vitamin D supply via formula milk was 
insufficient to treat their preexisting severe neonatal de-
ficiency.
 Prevention of maternal deficiency is critical, and all 
mothers should meet their nutritional requirement for 
vitamin D, which is currently set at 600 IU/day, although 
this value is not based on direct evidence from RCTs of 
vitamin D supplementation in pregnant women  [28] . Po-
tentially, a higher intake of vitamin D may be required to 
prevent both maternal and neonatal deficiency  [87] . Pre-
vention of congenital vitamin D deficiency is described in 
section 4.4.
 3.2 Early Feeding, Supplementation, Complementary 
Feeding, and Nutrient Intake Associated with 
Nutritional Rickets in Infants 
 3.2.1 Recommendations 
 • In addition to an intake of 400 IU/day of vitamin D, 
complementary foods introduced no later than 26 
weeks should include sources rich in calcium. 
(1 ⨁ ⨁ ⨁ ) 
 • An intake of at least 500 mg/day of elemental calcium 
must be ensured during childhood and adolescence. 
(1 ⨁ ⨁ ⨁ ) 
 Table 3.  Treatment doses of vitamin D for nutritional rickets
Age Daily dose for
90 days, IU
Single
dose, IU
Maintenance
daily dose, IU
<3 months 2,000 NA 400
3 – 12 months 2,000 50,000 400
>12 months to 12 years 3,000 – 6,000 150,000 600
>12 years 6,000 300,000 600
 NA = Not available. Reassess response to treatment after 3 
months as further treatment may be required. Ensure a daily cal-
cium intake of at least 500 mg. For conversion from IU to μg, di-
vide by 40.
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 3.2.2 Evidence 
 There is abundant, yet low-quality evidence from mul-
tiple case reports, case series  [11, 48, 49, 88] , and obser-
vational studies  [1, 2, 45, 50, 85, 89–99] that exclusive 
breast-feeding without vitamin D supplementation is a 
major risk factor for NR in infants. Furthermore, pro-
longed breast-feeding with late introduction of comple-
mentary feeding is associated with NR in infants not re-
ceiving vitamin D supplements  [26, 100–105] . Abundant 
observational data  [55, 106–111] and an RCT  [25] suggest 
that infants receiving vitamin D supplementation in the 
first year of life are not at risk of developing NR. Evidence 
for providing 400 IU/day vitamin D to infants is present-
ed in section 2.1.
 Evidence primarily from developing countries dem-
onstrates that traditional diets low in calcium cause NR 
 [30, 43, 69, 93, 112–114] . Therefore, special diets during 
infancy such as those that avoid milk and dairy products, 
those using soy or rice milk that are not specifically de-
signed for infants, and/or vegan and macrobiotic diets 
may predispose infants to NR  [115–120] . Recommen-
dations on sufficient calcium intake are presented in sec-
tion 1.4.
 3.3 Association of Sunlight Exposure to Nutritional 
Rickets 
 3.3.1 Recommendations 
 • Because ultraviolet B (UVB) rays trigger the epidermal 
synthesis of previtamin D 3 , restricted exposure to sun 
increases the risk of vitamin D deficiency and NR. 
(1 ⨁ ⨁ ⨁ ) 
 • Environmental factors such as latitude, season, time 
of day, cloud cover, and pollution affect the availabil-
ity of UVB, whereas personal factors such as time 
spent outdoors, skin pigmentation, skin coverage, 
age, body composition, and genetics affect the dose 
response to UVB exposure and circulating 25OHD. 
(2 ⨁ ⨁ ○) 
 • No safe threshold of UV exposure allows for sufficient 
vitamin D synthesis across the population without in-
creasing skin cancer risk. (2 ⨁ ⨁ ○) 
 3.3.2 Evidence 
 Solar radiation (UVB band of 290–315 nm) stimulates 
synthesis of previtamin D from epidermal 7-dehydro-
cholesterol, which isomerizes to cholecalciferol and is 
subsequently metabolized to 25OHD. Sun exposure in-
creases circulating 25OHD  [121–123] . Assuming UVB 
availability, an individual’s capacity to synthesize vita-
min D increases with longer epidermal exposure. How-
ever, exposure can be affected by environmental factors 
such as latitude, altitude, season, time of day, cloud cov-
er, and air quality  [123–129] as well as personal factors 
such as occupation, lifestyle, culture such as clothing, 
and preference which may modify the time spent out-
doors and/or the surface area of skin exposed to sunlight 
 [130–133] . Finally, the dose response of circulating 
25OHD to cutaneous UVB exposure is dependent on 
skin pigmentation, age, body composition, genetic fac-
tors, and baseline 25OHD levels, among others  [121, 131, 
134–138] .
 Abundant global observational data report an associa-
tion between restricted epidermal exposure and NR as a 
consequence of vitamin D deficiency  [85, 139–143] . UV 
radiation causes skin cancer, and exposure to UV radia-
tion from sunlight and artificial sources early in life ele-
vates the risk of developing skin cancer  [144] . Without 
firm evidence to account for variations in age, skin color, 
latitude, time of day, and time of year, it is currently im-
practical to provide prescriptive advice on safe solar ex-
posure to the population as a whole. All risk factors are 
summarized in  table 2 .
 4 Prevention of Osteomalacia during Pregnancy and 
Lactation and Congenital Rickets 
 4.1 The Relationship between Vitamin D during 
Pregnancy and Infant Growth and Bone Mass 
 4.1.1 Recommendations 
 • Pregnant women should receive 600 IU/day of sup-
plemental vitamin D. This will ensure adequacy of 
maternal 25OHD, especially in women at risk of defi-
ciency, to prevent elevated cord blood ALP, increased 
fontanelle size, neonatal hypocalcemia and congeni-
tal rickets, and to improve dental enamel formation. 
(2 ⨁ ⨁ ○) 
 • There is little evidence that maternal supplementation 
with vitamin D will protect or improve birth anthro-
pometry (2 ⨁ ⨁ ○), and there is no evidence that sup-
plementation with vitamin D will protect or improve 
short- or long-term growth or bone mass accretion. 
(2 ⨁ ⨁ ○) 
 4.1.2 Evidence 
 There is moderate evidence that low maternal vitamin 
D status during pregnancy is associated with elevated 
cord blood ALP and larger fontanelle size at birth  [145, 
146] . Moderate to strong evidence from 2 RCTs  [145, 
147] , 2 controlled trials  [148, 149] , and 1 observational 
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study  [150] indicated that low maternal vitamin D status 
during pregnancy increases the risk of neonatal hypocal-
cemia; however, a smaller RCT and a controlled trial did 
not support these findings  [146, 151] . A single large con-
trolled trial suggests that vitamin D supplementation 
during pregnancy improves dental enamel formation of 
offspring  [148] .
 There are conflicting data about the association be-
tween maternal vitamin D status during pregnancy and 
birth anthropometry. Three RCTs of moderate to high 
quality using daily dose or single high-dose regimens did 
not find an association  [151–153] , whereas 2 controlled 
trials of moderate-grade evidence found a positive asso-
ciation  [146, 147] . Three low- to high-quality RCTs did 
not find any difference in birth anthropometry in off-
spring of mothers supplemented with 400, 2,000, or 4,000 
IU/day; none of the studies had a placebo group  [87, 154, 
155] .
 There are inconsistent data on the association between 
maternal serum 25OHD levels and linear growth during 
the first year of life  [152, 156–158] and insufficient to 
weak evidence for an association between maternal se-
rum 25OHD levels and bone mass or density at birth 
 [150, 159–162] or in later childhood  [158, 163, 164] .
 4.2 The Effect of Calcium Supplementation during 
Pregnancy on Infant Bone Mass 
 4.2.1 Recommendation 
 • Pregnant women do not need calcium intakes above 
recommended nonpregnant intakes to improve neo-
natal bone. (1 ⨁ ⨁ ⨁ ) 
 4.2.2 Evidence 
 Calcium supplementation studies in pregnancy have 
not had congenital or neonatal rickets as an outcome, but 
3 RCTs of maternal calcium supplementation during 
pregnancy measured neonatal bone  [165–167] . These 
RCTs were conducted in West Africa where typical di-
etary calcium intakes are 250–300 mg/day  [165] , in the 
United States with an average intake of about 2,000 mg/
day  [166] , and in a multicenter World Health Organi-
zation study in populations with dietary calcium intake 
of approximately 600 mg/day (Argentina, Peru, India, 
Egypt, Vietnam, South Africa)  [167] . Maternal calcium 
supplementation had no effect on neonatal bone mineral 
assessed by dual-energy X-ray absorptiometry in the 
Gambian and US studies, except in the latter study in the 
offspring of women in the lowest quintile of dietary cal-
cium intake (<600 mg/day). There was no effect of mater-
nal calcium supplementation on neonatal or infant an-
thropometry, a finding consistent with observational 
studies.
 4.3 Influence of Calcium or Vitamin D 
Supplementation in Pregnancy or Lactation on Breast 
Milk Calcium or Vitamin D 
 4.3.1 Recommendations 
 • Lactating women should ensure they meet the dietary 
recommendations for vitamin D (600 IU/day) for their 
own needs, but not for the needs of their infant. 
(1 ⨁ ⨁ ⨁ ) 
 Fig. 2. Double-blind RCTs have shown that 
maternal intakes of 1,000–6,400 IU/day of 
vitamin D are associated with increased 
breast milk vitamin D concentrations  [156, 
168, 169, 171] . Lines of similar color repre-
sent the same study, and the legend pro-
vides the vitamin D supplementation dose 
(IU/day unless otherwise stated). Oberhel-
man et al.  [171] reported milk concentra-
tions of cholecalciferol only. 
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 • Lactating women should not take high amounts of vi-
tamin D as a means of supplementing their infant. 
(2 ⨁ ⨁ ○) 
 • Pregnant and lactating women should meet the rec-
ommended intakes of calcium. Maternal calcium in-
take during pregnancy or lactation is not associated 
with breast milk calcium concentrations. (1 ⨁ ⨁ ⨁ ) 
 4.3.2 Evidence 
 Maternal vitamin D intake during lactation corre-
lates with milk vitamin D activity. Several double-blind 
RCTs found that high maternal intakes of vitamin D 
(2,000, 4,000, and 6,400 IU/day) were associated with a 
higher breast milk vitamin D concentration ( fig.  2 ) 
 [168–171] .
 Supplementing mothers with high amounts of vitamin 
D has been suggested as a means of increasing both ma-
ternal ( fig. 3 ) and infant serum 25OHD concentrations 
 [172–175] . Maternal vitamin D intakes up to 4,000 IU/
day are likely safe during pregnancy and lactation  [16] . 
However, the finding that infants of mothers supple-
mented with 2,000 IU/day or more have similar serum 
25OHD concentrations as infants receiving 400 IU/day 
( fig. 4 ), as well as safety concerns, and our own recom-
mendation that all infants receive 400 IU vitamin D per 
day lead us to advise that mothers should take recom-
mended amounts (600 IU/day) rather than higher doses 
of vitamin D.
 Maternal calcium intake during pregnancy or lacta-
tion does not influence breast milk calcium concentra-
tions. Only 1 observational study found a weak associa-
tion between maternal calcium intakes during pregnancy 
and breast milk calcium level at day 40 (mature milk) 
 [176] . Numerous studies, including 2 RCTs  [177, 178] 
and 2 observational studies  [179, 180] , have not found a 
relationship between maternal calcium intake and breast 
milk calcium concentrations.
 No studies have investigated the effect of maternal vi-
tamin D intake during pregnancy on either milk calcium 
or vitamin D concentrations. Two double-blind RCTs 
found that maternal serum 25OHD concentration or ma-
ternal intake of vitamin D (up to 4,000 IU/day) during 
lactation was not associated with milk calcium concentra-
tions  [181, 182] .
 4.4 Causes and Therapy of Congenital Rickets 
 4.4.1 Recommendation 
 • Supplementing mothers with 600 IU/day of vitamin D 
and ensuring they receive recommended calcium in-
takes, or appropriate therapy of maternal conditions 
predisposing to hypocalcemia or vitamin D deficiency, 
prevents congenital rickets. (2 ⨁ ○ ○) 
 Fig. 3. Double-blind RCTs have shown that 
maternal serum 25OHD concentrations 
are increased with vitamin D supplementa-
tion  [169, 171, 174, 182] . Most trials began 
supplementation shortly after birth. Mark-
ers of similar color represent the same 
study, and the legend provides the vitamin 
D supplementation dose (in IU/day unless 
otherwise stated). 1 ng/ml = 2.5 nmol/l. 
Wtr = Winter; Sum = summer. 
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 4.4.2 Evidence 
 Approximately 80 cases of congenital rickets, defined 
as babies presenting within the first 4 weeks of life with 
biochemical and radiographic signs of rickets, have been 
described in the medical literature. Typically, mothers of 
babies with congenital rickets have osteomalacia with se-
vere vitamin D deficiency, low calcium intake, and hypo-
calcemia at delivery and had not taken vitamin D supple-
mentation during pregnancy  [83, 183–197] . In rare cases, 
congenital rickets can occur when mothers have had se-
vere prolonged hypocalcemia not primarily caused by 
 vitamin D deficiency such as poorly treated hypopara-
thyroidism  [198–201] , renal failure  [202–206] , received 
phosphate-containing enemas  [207] , or iatrogenic hyper-
magnesemia  [208] .
 The mechanisms for the development of congenital 
rickets remain poorly understood, especially how di-
minished maternal calcium supply as the common pri-
mary maternal abnormality in all cases affects fetal min-
eralization. Clearly, congenital rickets only occurs in 
 extreme metabolic situations. It is fair to state that all 
reported cases of congenital rickets could have been pre-
vented by vitamin D supplementation, normal calcium 
intake during pregnancy, and adequate therapy of ma-
ternal conditions associated with prolonged hypocalce-
mia or vitamin D deficiency. Evidence is very limited on 
the therapy for congenital rickets, but rickets is gener-
ally responsive to vitamin D with or without calcium 
supplementation.
 5 Assessing the Burden of Nutritional Rickets and 
Public Health Strategies for Prevention 
 5.1 Assessment of Disease Burden 
 5.1.1 Recommendations 
 • The prevalence of rickets should be determined by 
population-based samples, by case reports from senti-
nel centers, or by mandatory reporting. (1 ⨁ ⨁ ⨁ ) 
 • Screening for NR should be based on clinical features, 
followed by radiographic confirmation of suspected 
cases. (1 ⨁ ⨁ ⨁ ) 
A B
 Fig. 4. Infant serum 25OHD concentrations by age in RCTs where either the mother was supplemented with vi-
tamin D ( A ) or the infant was supplemented ( B )  [171, 173, 175, 182] . Markers of similar color represent the same 
study, and the legend provides the vitamin D supplementation dose (in IU/day unless otherwise stated). 1 ng/
ml = 2.5 nmol/l. Wtr = Winter; Sum = summer. 
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 • Population-based screening with serum 25OHD, se-
rum ALP, or radiographs is not indicated. (1 ⨁ ⨁ ⨁ ) 
 5.1.2 Evidence 
 NR has been increasingly reported in high- and low-
income countries  [55, 209–213] . Using different method-
ology, the incidence of NR has been reported as 2.9, 4.9, 
7.5, and 24 per 100,000 in Canada  [1] , Australia  [2] , the 
United Kingdom  [3] , and the United States  [99] , respec-
tively. Many studies are hospital based but provide addi-
tional insight into the burden of NR. Infants with NR may 
present with hypocalcemic seizures. The incidence of di-
lated cardiomyopathy associated with NR and hypocalce-
mia is unknown, but it is potentially the deadliest and 
most economically costly complication of NR  [11] . The 
methods used for the diagnosis of NR in case reports 
 [102] and small to large case series  [104, 214–217] are 
widely variable, and many lack radiographic confirma-
tion  [209] . Physician-based surveys can estimate the bur-
den of disease, but few have been done  [1, 2] . Population-
based studies provide the most accurate assessment of the 
disease burden  [3, 99, 211, 218–221] . Despite differing 
methodologies, published reports indicate the greatest 
burden of NR is in Africa, Asia, and the Middle East due 
to sun avoidance or dietary calcium insufficiency  [209, 
213] .
 Even high-income countries have observed a resur-
gence of NR, mainly among immigrants of African, Asian, 
or Middle-Eastern origin. This overall increase in the in-
cidence of NR in high-income countries corresponds to 
an increase in the number of individuals in ethnic minor-
ity, immigrant, and refugee groups  [1–4, 99, 222] . The 
incidence among established Caucasian populations is 
stable or decreasing. In regions with a low prevalence of 
NR, inclusion of NR as a reportable disease is potentially 
the most cost-effective means of case identification and 
surveillance  [1, 2, 4, 99, 222] .
 Measurement of serum 25OHD is useful for the diag-
nosis of vitamin D deficiency in NR, but not for popula-
tion screening  [223, 224] . Raised serum ALP has been 
used as a screening tool for NR  [225] . However, acute ill-
ness, drugs, liver disease, growth spurts, and transient hy-
perphosphatasemia of infancy and childhood can all ele-
vate ALP values. Because of the invasiveness of veni-
puncture, high cost, and low positive predictive values, 
serum ALP and 25OHD cannot be recommended for 
population screening. Although radiographs of the wrists 
and knees provide definitive confirmation of active rick-
ets  [226] , radiation exposure precludes recommending 
screening radiographs in asymptomatic children.
 5.2 Public Health Strategies for Rickets Prevention 
 5.2.1 Recommendations 
 • Universally supplement all infants with vitamin D 
from birth to 12 months of age, independently of their 
mode of feeding. Beyond 12 months, supplement all 
groups at risk and pregnant women. Vitamin D sup-
plements should be incorporated into childhood pri-
mary health care programs along with other essential 
micronutrients and immunizations (1 ⨁ ⨁ ⨁ ), and 
into antenatal care programs along with other recom-
mended micronutrients. (2 ⨁ ⨁ ○) 
 • Recognize NR, osteomalacia, and vitamin D and cal-
cium deficiencies as preventable global public health 
problems in infants, children, and adolescents. 
(1 ⨁ ⨁ ⨁ ) 
 • Implement rickets prevention programs in populations 
with a high prevalence of vitamin D deficiency or lim-
ited vitamin D and/or calcium intakes and in groups of 
infants and children at risk of rickets. (1 ⨁ ⨁ ⨁ ) 
 • Monitor adherence to recommended vitamin D and 
calcium intakes and implement surveillance for NR. 
(1 ⨁ ⨁ ⨁ ) 
 • Fortify staple foods with vitamin D and calcium, as ap-
propriate, based on dietary patterns. Food fortification 
can prevent rickets and improve vitamin D status of 
infants, children, and adolescents if appropriate foods 
are used and sufficient fortification is provided, if for-
tification is supported by relevant legislation, and if the 
process is adequately monitored. Indigenous food 
sources of calcium should be promoted or subsidized 
in children. (1 ⨁ ⨁ ⨁ ) 
 • Promote addressing the public health impact of vita-
min D deficiency as both a clinical and a public health 
issue. (1 ⨁ ⨁ ⨁ ) 
 5.2.2 Evidence 
 5.2.2.1 Vitamin D Supplementation.  Infants aged 0–12 
months and adolescents are at an increased risk of NR 
and osteomalacia from vitamin D deficiency due to rapid 
growth. Vitamin D is found in a limited number of foods, 
and dietary intakes apart from fortified foods have little 
impact on overall vitamin D status. Programs that deliver 
micronutrient supplements provide the fastest improve-
ment in micronutrient status of individuals or targeted 
populations  [227, 228] .
 5.2.2.2 Food Fortification with Vitamin D.  Food forti-
fication of commonly consumed staple foods safely pro-
vides adequate intake to prevent deficiency at minimal 
cost. Mandatory fortification of staple foods with vitamin 
D and calcium ensures nutritional adequacy  [229] . After 
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vitamin D fortification of milk in North America and of 
milk, margarine, and cereals in the United Kingdom, the 
prevalence of NR dramatically declined, so much so that 
it was considered almost eradicated  [16, 63, 228] .
 Studies in adults and children highlight the need for 
appropriate foods  [230] to be adequately fortified and 
consumed by the at-risk segments of the population  [231] 
so that vitamin D intakes of most members of a popula-
tion approach dietary recommendations  [232, 233] . Be-
cause vitamin D fortification of foods rich in calcium is 
optimal for bone health, dairy products are commonly 
fortified. In countries where dairy products are not wide-
ly consumed, flour, margarine, cooking oil, or soy-based 
foods can be fortified with vitamin D.
 Although several studies have assessed the effective-
ness of vitamin D fortification of food to increase 25OHD 
concentrations in different age groups and communities, 
relatively few fortification studies have targeted children. 
A systematic review and meta-analysis concluded from 
food-based RCTs that vitamin D-fortified foods increase 
serum 25OHD and reduce the prevalence of deficiency 
(<30 nmol/l) in adults, provided appropriate vehicles are 
chosen based on analysis of habitual diet  [234] . Fortifica-
tion of chupatty flour (6,000 IU/kg) raised 25OHD from 
approximately 12.5 nmol/l to approximately 48 nmol/l in 
children over a 6-month period  [235] . Fortification of flu-
id milk and margarine was estimated to increase vitamin 
D intake in 4-year-old children from 176 to 360 IU/day 
(4.4 to 9 μg/day) and 25OHD concentrations from 55 to 
65 nmol/l  [236] . Milk fortification has also been a success-
ful strategy to improve the vitamin D status of schoolchil-
dren in India  [237] . Fortification and supplementation 
requirements may vary with population exposure to sun-
shine (see section 3)  [238] .
 5.2.2.3 Food Fortification with Calcium. Inadequate di-
etary calcium intake is a risk factor for NR in children over 
the age of 12 months with low dairy product intake, a com-
mon situation in low-income countries. The IOM recom-
mends a calcium intake of 500 mg/day in children aged 1–3 
years when children are at the greatest risk of NR, based on 
calcium retention in absorption studies  [16] . In populations 
with low dairy intake such as in Africa and parts of Asia, 
indigenous food sources of calcium or fortification of staple 
foods with calcium can provide adequate calcium intake in 
children  [213, 239] . Calcium salts can be used to fortify in-
fant formulas, complementary foods, and staple food in ar-
eas where dairy intake is low. Calcium carbonate for food 
fortification is available at very low cost  [227] .
 Food fortification effectively increased dietary calcium 
intakes by using calcium-fortified laddoos in the diet of 
underprivileged Indian toddlers  [240] and by calcium for-
tification of cereal for 7- to 12-year-old children  [241] . 
More than 1,100 foods are calcium fortified in the United 
States, yet dairy food makes up more than 65% of adoles-
cents’ calcium intake  [242] . In the United Kingdom, cal-
cium fortification of flour is an important source of cal-
cium intake (16% of total) for young adolescent girls  [243] . 
There are limited data from studies on calcium fortifica-
tion or the acceptability of dietary diversification to in-
clude locally available and affordable calcium-rich foods 
in developing countries. Periodic monitoring for NR is 
important to determine the effectiveness of fortification 
and/or supplementation programs in preventing NR.
 5.2.2.4 Health Promotion.  Education of medical provid-
ers and organizations, health insurers, policy makers, gov-
ernments, public health officials, and the general public is 
vital to address the public health issue of NR and vitamin 
D deficiency. They should be provided with guidelines on 
the importance of adequate vitamin D and calcium intakes 
in children, adolescents, and pregnant and lactating wom-
en  [244] . National and global public health promotion 
strategies are essential to raise professional and commu-
nity awareness, and global action to protect all children 
from vitamin D and calcium deficiency is imperative.
 5.3 Economic Cost/Benefits of Prevention Programs 
 5.3.1 Recommendation 
 • The cost-effectiveness of supplementation and food 
fortification programs needs further study. (1 ⨁ ⨁ ○) 
 5.3.2 Evidence 
 Very weak evidence supports a policy of providing vi-
tamin D supplementation to Asian children in the United 
Kingdom for the first 2 years of life  [245] . However, this 
report had methodological limitations that preclude any 
conclusions.
 Urgent research is required to model the cost-effec-
tiveness of alternative vitamin D supplementation strate-
gies and food fortification programs. Future economic 
models should include:
 • Resources associated with different supplementation 
strategies 
 • Indirect costs of treatment and complications 
 • Resource use of current practice 
 • Effectiveness of different approaches 
 • Expected adherence 
 • Outcomes such as quality of life associated with
 25OHD levels, and 
 • Health care costs of disease caused by both skeletal and 
extraskeletal effects of vitamin D deficiency 
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 Costs of vitamin D supplementation and/or fortifica-
tion programs will differ depending on the target 25OHD 
level and population characteristics. Subgroup analyses 
targeting high-risk groups, such as people with darkly 
pigmented skin, limited sun exposure, and low calcium 
intakes, should be conducted.
 Conclusion 
 Vitamin D deficiency should be considered a major 
global public health priority. NR can have severe conse-
quences, including death from cardiomyopathy or ob-
structed labor, myopathy, seizures, pneumonia, lifelong de-
formity and disability, impaired growth, and pain. NR is the 
‘tip of the iceberg’, and its resurgence indicates widespread 
vitamin D deficiency with important public health implica-
tions. NR and osteomalacia are fully preventable disorders 
that are on the rise worldwide and should be regarded as a 
global epidemic. We advocate for the eradication of NR and 
osteomalacia through vitamin D supplementation of all in-
fants, pregnant women, and individuals from high-risk 
groups and the implementation of international food forti-
fication programs to ensure nutritional sufficiency of vita-
min D and calcium for the whole population. This consen-
sus document provides policy makers with a reference 
framework to work toward the global eradication of rickets.
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